SB012
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SB012, covering 2018-03-09 to 2018-03-09. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients [Phase 1, Phase 2]